Cardiovascular Resources
Expert Videos
SGLT-2i and HFrEF
Prof Sindone speaks about the role of the GP in optimising to GDMT with an SGLT-2i, regardless of T2D status.
STOP-or-NOT & ABYSS Trials
Prof. John Amerena highlights new insights into advanced treatment strategies for heart failure patients based on the latest clinical research.
Spotlight on Heart Failure Management: When should comprehensive therapies be initiated?
Dr. Javed Butler outlines his approach to ensure optimal initiation of comprehensive therapy for heart failure management.
Treating Patients with Heart Failure with Prof. Zaheer Yousef
Prof. Zaheer Yousef shares a quick (~1 min) commentary on treating patients with reduced and preserved ejection fraction with results from the DAPA-HF and DELIVER trials.
Spotlight on Heart Failure with Reduced Ejection Fraction: Cardiologists’ Perspective
Dr Javed Butler gives his perspective on “stable” heart failure and the risk factors to be aware of when assessing patients.
Spotlight on Heart Failure: The Impact of Early Detection
Dr Javed Butler discusses his perspective on the factors that interfere with the early detection of heart failure and how to address these factors when assessing your patients.
Spotlight on Heart Failure: The Impact of Treatment Delay
Dr Javed Butler highlights the impact of treatment delay on patients with heart failure and how acting earlier can have positive outcomes on patient functioning.
Spotlight on Heart Failure: A Cardiologist's Perspective
Professor Mark Petrie in this video answers the question: Is there such a thing as “stable heart failure patients”?
Importance of Early Referral in HF by Primary Care
General Practitioner Dr Naresh Kanumilli discusses the importance of early referral for patients with heart failure early and the role primary care plays in this process.
Early treatment for Chronic Heart Failure patients
General Practitioner Dr Gary Deed discusses the importance of treating patients with heart failure early and the role primary care plays in this process.
Understanding HFpEF vs HFrEF
Explore the crucial differences between the two common types of Heart Failure: HFpEF (Heart Failure with Preserved Ejection Fraction) and HFrEF (Heart Failure with Reduced Ejection Fraction).
Healthcare Professional Resources
Explore resources tailored to support your everyday practice.
Research Review: DAPA-HF and DELIVER Study Review
Quick look at the combined trial data exploring dapagliflozin use across the entire ejection fraction range in heart failure care.
DAPA-HF Clinical Trial Summary
A concise overview of the DAPA HF study design, patient profile, primary endpoints, and the CKD related PBS listing details for dapagliflozin.
DELIVER
Clinical Trial Summary
A brief snapshot of the DELIVER trial’s design and key endpoints in HF with mildly reduced/preserved EF, plus the most recent PBS listing context for dapagliflozin.
Consensus statement of Australian clinicians for the pharmacological management of heart failure
You might also be interested in
Want to know more?
If you have any questions or would like to be kept updated on new training
resources please subscribe to our email newsletter or reach out below.
Loading......
Loading......
